Open original FDA record ↗Recall record
- FDA identifier
- Z-1523-2018
- Company in FDA record
- Sofradim Production
- FDA classification date
- Apr 26, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
There have been patient reports of abdominal hernia recurrence following hernia repair. The recalling firm has added a statement to the device's Instructions for Use to make surgeons aware of risks in using the device in Transversus Abdominis Muscle Release (TAR) procedures.
Source facts
- Action
- All consignees were notified via Federal Express or certified mail on February 23, 2018. Customers were advised of the added warning on the product labeling. Customers were requested to acknowledge receipt and understanding of the Urgent Field Corrective Action Notice. Customers with questions were directed to contact their Medtronic Representative, or Customer Service at 800-962-9888, option 2.
- Initiated
- 2018-02-23
- Root cause
- Other
- Terminated
- 2020-05-12
- Distribution
- Worldwide Distribution - USA (nationwide) Distribution to the states of: CA, CT, FL, GA, IL, IN, KY, MA, MD, MI, MN, MO, NC, NH, NJ, NV, NY, OH, PA, TN, TX, VA, WA and WI, and to the countries of : Belgium, Finland, France, Germany, Ireland, Israel, Italy, Netherlands, Russian Federation, Spain, Switzerland, and UK.
- Recall number
- Z-1523-2018
- Recall status
- Terminated
- CDRH record ID
- 162927
- FDA classified
- 2018-04-26
- Recall event number
- 79662